Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nationwide validation study of diagnostic algorithms for inflammatory bowel disease in Korean National Health Insurance Service database.
Lee CK, Ha HJ, Oh SJ, Kim JW, Lee JK, Kim HS, Yoon SM, Kang SB, Kim ES, Kim TO, Na SY, Lee J, Kim SW, Koo HS, Park BK, Lee HH, Kim ES, Park JJ, Kwak MS, Cha JM, Ye BD, Choi CH, Kim HJ. Lee CK, et al. Among authors: choi ch. J Gastroenterol Hepatol. 2020 May;35(5):760-768. doi: 10.1111/jgh.14855. Epub 2019 Oct 27. J Gastroenterol Hepatol. 2020. PMID: 31498502
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases.
Park SK, Choi CH, Chun J, Lee H, Kim ES, Park JJ, Park CH, Lee BI, Jung Y, Park DI, Kim DY, Park H, Jeen YT; IBD Research Group of the Korean Association for the Study of Intestinal Diseases. Park SK, et al. Among authors: choi ch. Intest Res. 2020 Jan;18(1):18-33. doi: 10.5217/ir.2019.09155. Epub 2020 Jan 30. Intest Res. 2020. PMID: 32013312 Free PMC article. Review.
Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study.
Kim J, Yoon H, Kim N, Lee KM, Jung SA, Choi CH, Kim ES, Jung Y, Eun CS, Kim TO, Kang SB, Kim YS, Seo GS, Lee CK, Im JP, Park SJ, Park DI, Ye BD. Kim J, et al. Among authors: choi ch. Inflamm Bowel Dis. 2021 Nov 15;27(12):1931-1941. doi: 10.1093/ibd/izaa361. Inflamm Bowel Dis. 2021. PMID: 33501935
Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study.
Song JH, Kang EA, Park SK, Hong SN, Kim YS, Bang KB, Kim KO, Lee HS, Kang SB, Shin SY, Song EM, Im JP, Choi CH; IBD Research Group of the Korean Association for the Study of Intestinal Diseases. Song JH, et al. Among authors: choi ch. Gut Liver. 2021 Sep 15;15(5):752-762. doi: 10.5009/gnl20233. Gut Liver. 2021. PMID: 33767028 Free PMC article.
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study.
Shin SY, Park SJ, Kim Y, Im JP, Kim HJ, Lee KM, Kim JW, Jung SA, Lee J, Kang SB, Shin SJ, Kim ES, Kim YS, Kim TO, Kim HS, Park DI, Kim HK, Kim ES, Kim YH, Kim DH, Teng D, Kim JH, Kim W, Choi CH; IBD Research Group of the Korean Association for the Study of Intestinal Diseases. Shin SY, et al. Among authors: choi ch. Intest Res. 2022 Jul;20(3):350-360. doi: 10.5217/ir.2021.00049. Epub 2021 Jul 23. Intest Res. 2022. PMID: 34289648 Free PMC article.
Comparison of the Pharmacokinetics of CT-P13 Between Crohn's Disease and Ulcerative Colitis.
Kim ES, Kim SK, Park DI, Kim HJ, Lee YJ, Koo JS, Kim ES, Yoon H, Lee JH, Kim JW, Shin SJ, Kim HW, Kim HS, Park YS, Kim YS, Kim TO, Lee J, Choi CH, Han DS, Chun J, Kim HS; IBD Research Group in the Korean Association for the Study of Intestinal Diseases. Kim ES, et al. Among authors: choi ch. J Clin Gastroenterol. 2023 Jul 1;57(6):601-609. doi: 10.1097/MCG.0000000000001715. J Clin Gastroenterol. 2023. PMID: 35470308
1,653 results